- Home
- OUST vs SMTI Comparison
OUST vs SMTI Comparison
Compare OUST & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OUST | SMTI |
|---|---|---|
| Founded | 2015 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 186.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | OUST | SMTI |
|---|---|---|
| Price | $22.53 | $25.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $31.33 | ★ $41.00 |
| AVG Volume (30 Days) | ★ 1.8M | 52.0K |
| Earning Date | 11-04-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $137,298,000.00 | $101,877,532.00 |
| Revenue This Year | $35.72 | $21.60 |
| Revenue Next Year | $35.65 | $16.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 30.20 | ★ 30.52 |
| 52 Week Low | $6.34 | $18.90 |
| 52 Week High | $41.65 | $38.68 |
Technical Indicators
Market Signals| Indicator | OUST | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 42.90 | 57.75 |
| Support Level | $24.45 | $20.06 |
| Resistance Level | $26.59 | $27.00 |
| Average True Range (ATR) | 1.60 | 1.28 |
| MACD | 0.21 | 0.83 |
| Stochastic Oscillator | 16.56 | 75.65 |
Price Performance
Historical ComparisonAbout OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.